Suita, Japan

Kazumi Niidome

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Dainippon Pharma Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazumi Niidome. Retrieved from https://idiyas.com/inventor/kazumi-niidome

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazumi Niidome: Innovator in Pharmaceutical Chemistry

Introduction

Kazumi Niidome is a notable inventor based in Suita, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Kazumi Niidome holds a patent for a compound known as 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof. This patent represents a significant advancement in the development of pharmaceutical agents, showcasing her expertise in creating effective medicinal compounds.

Career Highlights

Niidome is associated with Sumitomo Dainippon Pharma Co., Ltd., where she has been instrumental in various research initiatives. Her work has contributed to the advancement of pharmaceutical sciences, particularly in the area of drug development.

Collaborations

Throughout her career, Kazumi Niidome has collaborated with esteemed colleagues, including Toshiyuki Kamei and Takafumi Matsumoto. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Kazumi Niidome's contributions to pharmaceutical chemistry and her innovative spirit exemplify the impact of dedicated inventors in the field. Her work continues to influence the development of new therapeutic agents, making her a significant figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…